The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression
Open accessAbstract
Multiple, complex molecular events characterize cancer development and progression. Deciphering the molecular networks that distinguish organ-confined disease from metastatic disease may lead to the identification of critical biomarkers for cancer invasion and disease aggressiveness. Although gene and protein expression have been extensively profiled in human tumours, little is known about the global metabolomic alterations that characterize neoplastic progression. Using a combination of high-throughput liquid-and-gas-chromatography-based mass spectrometry, we profiled more than 1,126 metabolites across 262 clinical samples related to prostate cancer (42 tissues and 110 each of urine and plasma). These unbiased metabolomic profiles were able to distinguish benign prostate, clinically localized prostate cancer and metastatic disease. Sarcosine, an N-methyl derivative of the amino acid glycine, was identified as a differential metabolite that was highly increased during prostate cancer progression to metastasis and can be detected non-invasively in urine. Sarcosine levels were also increased in invasive prostate cancer cell lines relative to benign prostate epithelial cells. Knockdown of glycine-N-methyl transferase, the enzyme that generates sarcosine from glycine, attenuated prostate cancer invasion. Addition of exogenous sarcosine or knockdown of the enzyme that leads to sarcosine degradation, sarcosine dehydrogenase, induced an invasive phenotype in benign prostate epithelial cells. Androgen receptor and the ERG gene fusion product coordinately regulate components of the sarcosine pathway. Here, by profiling the metabolomic alterations of prostate cancer progression, we reveal sarcosine as a potentially important metabolic intermediary of cancer cell invasion and aggressivity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cluster analysis and display of genome-wide expression patterns
Eisen, M. B., Spellman, P. T., Brown, P. O., & Botstein, D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14863 · Cited by 16,184
A Direct Approach to False Discovery Rates
Storey, J. D. (2002) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/1467-9868.00346 · Cited by 5,603
Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer
Tomlins, S. A., Rhodes, D. R., Perner, S., Dhanasekaran, S. M., Mehra, R., Sun, X.-W., Varambally, S., Cao, X., Tchinda, J., Kuefer, R., et al. (2005) · Science · doi:10.1126/science.1117679 · Cited by 3,846
Self-citationRole of Histone H3 Lysine 27 Methylation in Polycomb-Group Silencing
Cao, R., Wang, L., Wang, H., Xia, L., Erdjument-Bromage, H., Tempst, P., Jones, R. S., & Zhang, Y. (2002) · Science · doi:10.1126/science.1076997 · Cited by 3,775
The polycomb group protein EZH2 is involved in progression of prostate cancer
Varambally, S., Dhanasekaran, S. M., Zhou, M., Barrette, T. R., Kumar-Sinha, C., Sanda, M. G., Ghosh, D., Pienta, K. J., Sewalt, R. G. A. B., Otte, A. P., et al. (2002) · Nature · doi:10.1038/nature01075 · Cited by 2,717
Self-citationKleer, C. G., Cao, Q., Varambally, S., Shen, R., Ota, I., Tomlins, S. A., Ghosh, D., Sewalt, R. G. A. B., Otte, A. P., Hayes, D. F., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1933744100 · Cited by 1,649
Self-citationRegulation of Cell Motility by Mitogen-activated Protein Kinase
Klemke, R. L., Cai, S., Giannini, A. L., Gallagher, P. J., Lanerolle, P. D., & Cheresh, D. A. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.137.2.481 · Cited by 1,235
Genomic Loss of microRNA-101 Leads to Overexpression of Histone Methyltransferase EZH2 in Cancer
Varambally, S., Cao, Q., Mani, R.-S., Shankar, S., Wang, X., Ateeq, B., Laxman, B., Cao, X., Jing, X., Ramnarayanan, K., et al. (2008) · Science · doi:10.1126/science.1165395 · Cited by 1,052
Self-citation[12] DNA arrays for analysis of gene expression
Eisen, M. B., & Brown, P. O. (1999) · Methods in Enzymology · doi:10.1016/s0076-6879(99)03014-1 · Cited by 1,032
Integrative molecular concept modeling of prostate cancer progression
Tomlins, S. A., Mehra, R., Rhodes, D. R., Cao, X., Wang, L., Dhanasekaran, S. M., Kalyana-Sundaram, S., Wei, J. T., Rubin, M. A., Pienta, K. J., et al. (2007) · Nature Genetics · doi:10.1038/ng1935 · Cited by 922
Self-citation
Research works printed but not linked: 1
- Varambally, S. et al. The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature 419, 624–629 (2002) · DOI · Paper page
Cited by
Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate
Ward, P. S., & Thompson, C. B. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.014 · Cited by 3,233
Metabolomics: beyond biomarkers and towards mechanisms
Johnson, C. H., Ivanisevic, J., & Siuzdak, G. (2016) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2016.25 · Cited by 2,829
HMDB 3.0—The Human Metabolome Database in 2013
Wishart, D. S., Jewison, T., Guo, A. C., Wilson, M., Knox, C., Liu, Y., Djoumbou, Y., Mandal, R., Aziat, F., Dong, E., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks1065 · Cited by 2,845
MassBank: a public repository for sharing mass spectral data for life sciences
Horai, H., Arita, M., Kanaya, S., Nihei, Y., Ikeda, T., Suwa, K., Ojima, Y., Tanaka, K., Tanaka, S., Aoshima, K., et al. (2010) · Journal of Mass Spectrometry · doi:10.1002/jms.1777 · Cited by 2,529
One-Carbon Metabolism in Health and Disease
Ducker, G. S., & Rabinowitz, J. D. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2016.08.009 · Cited by 2,239
“Sarcosine levels are elevated in aggressive and metastatic prostate cancer tumors (Sreekumar et al., 2009).”
BackgroundSerine, glycine and one-carbon units: cancer metabolism in full circle
Locasale, J. W. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3557 · Cited by 1,673
An atlas of genetic influences on human blood metabolites
The Multiple Tissue Human Expression Resource (MuTHER) Consortium, Shin, S.-Y., Fauman, E. B., Petersen, A.-K., Krumsiek, J., Santos, R., Huang, J., Arnold, M., Erte, I., Forgetta, V., et al. (2014) · Nature Genetics · doi:10.1038/ng.2982 · Cited by 1,515
Metabolite profiling identifies a key role for glycine in rapid cancer cell proliferation
Jain, M., Nilsson, R., Sharma, S., Madhusudhan, N., Kitami, T., Souza, A. L., Kafri, R., Kirschner, M. W., Clish, C. B., & Mootha, V. K. (2012) · Science · doi:10.1126/science.1218595 · Cited by 1,403
Evans, A. M., DeHaven, C. D., Barrett, T., Mitchell, M., & Milgram, E. (2009) · Analytical Chemistry · doi:10.1021/ac901536h · Cited by 1,333
Metabolomics for Investigating Physiological and Pathophysiological Processes
Wishart, D. S. (2019) · Physiological Reviews · doi:10.1152/physrev.00035.2018 · Cited by 1,212
Treating metastatic cancer with nanotechnology
Schroeder, A., Heller, D. A., Winslow, M. M., Dahlman, J. E., Pratt, G. W., Langer, R., Jacks, T., & Anderson, D. G. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3180 · Cited by 1,159
Biomarkers of Nutrition for Development—Folate Review
Bailey, L. B., Stover, P. J., McNulty, H., Fenech, M. F., Gregory, J. F., Mills, J. L., Pfeiffer, C. M., Fazili, Z., Zhang, M., Ueland, P. M., et al. (2015) · The Journal of Nutrition · doi:10.3945/jn.114.206599 · Cited by 1,136
Human metabolic individuality in biomedical and pharmaceutical research
CARDIoGRAM, Suhre, K., Shin, S.-Y., Petersen, A.-K., Mohney, R. P., Meredith, D., Wägele, B., Altmaier, E., Deloukas, P., Erdmann, J., et al. (2011) · Nature · doi:10.1038/nature10354 · Cited by 1,017
Molecular genetics of prostate cancer: new prospects for old challenges
Shen, M. M., & Abate-Shen, C. (2010) · Genes & Development · doi:10.1101/gad.1965810 · Cited by 946
How cancer metabolism is tuned for proliferation and vulnerable to disruption
Schulze, A., & Harris, A. L. (2012) · Nature · doi:10.1038/nature11706 · Cited by 929
Modern analytical techniques in metabolomics analysis
Zhang, A., Sun, H., Wang, P., Han, Y., & Wang, X. (2012) · The Analyst · doi:10.1039/c1an15605e · Cited by 877
Dunn, W. B., Broadhurst, D. I., Atherton, H. J., Goodacre, R., & Griffin, J. L. (2011) · Chem. Soc. Rev. · doi:10.1039/b906712b · Cited by 860
An Integrated Metabolic Atlas of Clear Cell Renal Cell Carcinoma
Hakimi, A. A., Reznik, E., Lee, C.-H., Creighton, C. J., Brannon, A. R., Luna, A., Aksoy, B. A., Liu, E. M., Shen, R., Lee, W., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2015.12.004 · Cited by 798
Metabolic targets for cancer therapy
Galluzzi, L., Kepp, O., Heiden, M. G. V., & Kroemer, G. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4145 · Cited by 711
Gall, W. E., Beebe, K., Lawton, K. A., Adam, K.-P., Mitchell, M. W., Nakhle, P. J., Ryals, J. A., Milburn, M. V., Nannipieri, M., Camastra, S., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010883 · Cited by 698
Analytical Methods in Untargeted Metabolomics: State of the Art in 2015
Alonso, A., Marsal, S., & JuliÃ, A. (2015) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2015.00023 · Cited by 681
Zhang, W. C., Shyh-Chang, N., Yang, H., Rai, A., Umashankar, S., Ma, S., Soh, B. S., Sun, L. L., Tai, B. C., Nga, M. E., et al. (2012) · Cell · doi:10.1016/j.cell.2011.11.050 · Cited by 660
Mayers, J. R., Wu, C., Clish, C. B., Kraft, P., Torrence, M. E., Fiske, B. P., Yuan, C., Bao, Y., Townsend, M. K., Tworoger, S. S., et al. (2014) · Nature Medicine · doi:10.1038/nm.3686 · Cited by 649
Metabolomics in cancer research and emerging applications in clinical oncology
Schmidt, D. R., Patel, R., Kirsch, D. G., Lewis, C. A., Vander Heiden, M. G., & Locasale, J. W. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21670 · Cited by 648
Erho, N., Crisan, A., Vergara, I. A., Mitra, A. P., Ghadessi, M., Buerki, C., Bergstralh, E. J., Kollmeyer, T., Fink, S., Haddad, Z., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066855 · Cited by 644
Zhou, B., Xiao, J. F., Tuli, L., & Ressom, H. W. (2011) · Molecular BioSystems · doi:10.1039/c1mb05350g · Cited by 639
Systems genetics approaches to understand complex traits
Civelek, M., & Lusis, A. J. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3575 · Cited by 621
Metabolomic Analysis and Visualization Engine for LC−MS Data
Melamud, E., Vastag, L., & Rabinowitz, J. D. (2010) · Analytical Chemistry · doi:10.1021/ac1021166 · Cited by 619
Mechanisms and Implications of Metabolic Heterogeneity in Cancer
Kim, J., & DeBerardinis, R. J. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.08.013 · Cited by 606
Organization of GC/MS and LC/MS metabolomics data into chemical libraries
DeHaven, C. D., Evans, A. M., Dai, H., & Lawton, K. A. (2010) · Journal of Cheminformatics · doi:10.1186/1758-2946-2-9 · Cited by 601
Chemometrics in metabolomics—A review in human disease diagnosis
Madsen, R., Lundstedt, T., & Trygg, J. (2010) · Analytica Chimica Acta · doi:10.1016/j.aca.2009.11.042 · Cited by 557
Metabolic Footprint of Diabetes: A Multiplatform Metabolomics Study in an Epidemiological Setting
Suhre, K., Meisinger, C., Döring, A., Altmaier, E., Belcredi, P., Gieger, C., Chang, D., Milburn, M. V., Gall, W. E., Weinberger, K. M., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013953 · Cited by 556
Vuckovic, D. (2012) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-012-6039-y · Cited by 532
Liquid chromatography–mass spectrometry based global metabolite profiling: A review
Theodoridis, G. A., Gika, H. G., Want, E. J., & Wilson, I. D. (2012) · Analytica Chimica Acta · doi:10.1016/j.aca.2011.09.042 · Cited by 518
Prostate Specific Antigen Best Practice Statement: 2009 Update
Greene, K. L., Albertsen, P. C., Babaian, R. J., Carter, H. B., Gann, P. H., Han, M., Kuban, D. A., Sartor, A. O., Stanford, J. L., Zietman, A., et al. (2009) · Journal of Urology · doi:10.1016/j.juro.2009.07.093 · Cited by 517
An Integrated Clinico-Metabolomic Model Improves Prediction of Death in Sepsis
Langley, R. J., Tsalik, E. L., Velkinburgh, J. C. V., Glickman, S. W., Rice, B. J., Wang, C., Chen, B., Carin, L., Suarez, A., Mohney, R. P., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005893 · Cited by 507
Metabolic oxidation regulates embryonic stem cell differentiation
Yanes, O., Clark, J., Wong, D. M., Patti, G. J., Sánchez-Ruiz, A., Benton, H. P., Trauger, S. A., Desponts, C., Ding, S., & Siuzdak, G. (2010) · Nature Chemical Biology · doi:10.1038/nchembio.364 · Cited by 506
Panopoulos, A. D., Yanes, O., Ruiz, S., Kida, Y. S., Diep, D., Tautenhahn, R., Herrerías, A., Batchelder, E. M., Plongthongkum, N., Lutz, M., et al. (2012) · Cell Research · doi:10.1038/cr.2011.177 · Cited by 495
Exogenous Alanine and/or Glucose plus Kanamycin Kills Antibiotic-Resistant Bacteria
Peng, B., Su, Y.-B., Li, H., Han, Y., Guo, C., Tian, Y.-M., & Peng, X.-X. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.01.008 · Cited by 481
Beyond PSA: The Next Generation of Prostate Cancer Biomarkers
Prensner, J. R., Rubin, M. A., Wei, J. T., & Chinnaiyan, A. M. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003180 · Cited by 472
Self-citationCurrent practice of liquid chromatography–mass spectrometry in metabolomics and metabonomics
Gika, H. G., Theodoridis, G. A., Plumb, R. S., & Wilson, I. D. (2014) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2013.06.032 · Cited by 442
Metabolic signatures of exercise in human plasma
Lewis, G. D., Farrell, L., Wood, M. J., Martinovic, M., Arany, Z., Rowe, G. C., Souza, A., Cheng, S., McCabe, E. L., Yang, E., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001006 · Cited by 432
Daemen, A., Peterson, D., Sahu, N., McCord, R., Du, X., Liu, B., Kowanetz, K., Hong, R., Moffat, J., Gao, M., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1501605112 · Cited by 398
MYC-driven accumulation of 2-hydroxyglutarate is associated with breast cancer prognosis
Terunuma, A., Putluri, N., Mishra, P., Mathé, E. A., Dorsey, T. H., Yi, M., Wallace, T. A., Issaq, H. J., Zhou, M., Killian, J. K., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci71180 · Cited by 428
“New essential metabolomic pathways for tumor growth have been described for breast and other cancers (4, 9–12), and “public” somatic mutations in metabolic enzymes were recently discovered.”
Self-citationIkeda, M., Tanida, T., Yoshii, T., Kurotani, K., Onogi, S., Urayama, K., & Hamachi, I. (2014) · Nature Chemistry · doi:10.1038/nchem.1937 · Cited by 422
Targeted Metabolomics for Biomarker Discovery
Griffiths, W. J., Koal, T., Wang, Y., Kohl, M., Enot, D. P., & Deigner, H. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.200905579 · Cited by 415
Challenges and emergent solutions for LC‐MS/MS based untargeted metabolomics in diseases
Cui, L., Lu, H., & Lee, Y. H. (2018) · Mass Spectrometry Reviews · doi:10.1002/mas.21562 · Cited by 415
Metabolic Characterization of Hepatocellular Carcinoma Using Nontargeted Tissue Metabolomics
Huang, Q., Tan, Y., Yin, P., Ye, G., Gao, P., Lu, X., Wang, H., & Xu, G. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-0308 · Cited by 414
Unravelling the complexity of metastasis — molecular understanding and targeted therapies
Sethi, N., & Kang, Y. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3125 · Cited by 397
Serum Metabolite Profiling of Human Colorectal Cancer Using GC−TOFMS and UPLC−QTOFMS
Qiu, Y., Cai, G., Su, M., Chen, T., Zheng, X., Xu, Y., Ni, Y., Zhao, A., Xu, L. X., Cai, S., et al. (2009) · Journal of Proteome Research · doi:10.1021/pr9004162 · Cited by 395
Bridgewater BR, E. A. (2014) · Journal of Postgenomics Drug & Biomarker Development · doi:10.4172/2153-0769.1000132 · Cited by 389
Lin, M., Song, P., Zhou, G., Zuo, X., Aldalbahi, A., Lou, X., Shi, J., & Fan, C. (2016) · Nature Protocols · doi:10.1038/nprot.2016.071 · Cited by 388
ETS Gene Fusions in Prostate Cancer: From Discovery to Daily Clinical Practice
Tomlins, S. A., Bjartell, A., Chinnaiyan, A. M., Jenster, G., Nam, R. K., Rubin, M. A., & Schalken, J. A. (2009) · European Urology · doi:10.1016/j.eururo.2009.04.036 · Cited by 381
Self-citationGuo, T., Kouvonen, P., Koh, C. C., Gillet, L. C., Wolski, W. E., Röst, H. L., Rosenberger, G., Collins, B. C., Blum, L. C., Gillessen, S., et al. (2015) · Nature Medicine · doi:10.1038/nm.3807 · Cited by 376
The role of metabolites and metabolomics in clinically applicable biomarkers of disease
Mamas, M., Dunn, W. B., Neyses, L., & Goodacre, R. (2011) · Archives of Toxicology · doi:10.1007/s00204-010-0609-6 · Cited by 376
Serum and Urine Metabolite Profiling Reveals Potential Biomarkers of Human Hepatocellular Carcinoma
Chen, T., Xie, G., Wang, X., Fan, J., Qiu, Y., Zheng, X., Qi, X., Cao, Y., Su, M., Wang, X., et al. (2011) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m110.004945 · Cited by 357
Stromal control of cystine metabolism promotes cancer cell survival in chronic lymphocytic leukaemia
Zhang, W., Trachootham, D., Liu, J., Chen, G., Pelicano, H., Garcia-Prieto, C., Lu, W., Burger, J. A., Croce, C. M., Plunkett, W., et al. (2012) · Nature Cell Biology · doi:10.1038/ncb2432 · Cited by 357
Kuehnbaum, N. L., & Britz-McKibbin, P. (2013) · Chemical Reviews · doi:10.1021/cr300484s · Cited by 354
Creek, D. J., Jankevics, A., Breitling, R., Watson, D. G., Barrett, M. P., & Burgess, K. E. V. (2011) · Analytical Chemistry · doi:10.1021/ac2021823 · Cited by 344
Mass spectrometric based approaches in urine metabolomics and biomarker discovery
Khamis, M. M., Adamko, D. J., & El‐Aneed, A. (2017) · Mass Spectrometry Reviews · doi:10.1002/mas.21455 · Cited by 342
Bernini, P., Bertini, I., Luchinat, C., Nincheri, P., Staderini, S., & Turano, P. (2011) · Journal of Biomolecular NMR · doi:10.1007/s10858-011-9489-1 · Cited by 332
Metabolomics in cancer biomarker discovery: Current trends and future perspectives
Armitage, E. G., & Barbas, C. (2014) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2013.08.041 · Cited by 331
Emerging molecular biomarkers—blood-based strategies to detect and monitor cancer
Hanash, S. M., Baik, C. S., & Kallioniemi, O. (2011) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.220 · Cited by 328
Metabolomics Applied to Diabetes Research
Bain, J. R., Stevens, R. D., Wenner, B. R., Ilkayeva, O., Muoio, D. M., & Newgard, C. B. (2009) · Diabetes · doi:10.2337/db09-0580 · Cited by 328
Comprehensive metabolomics expands precision medicine for triple-negative breast cancer
Xiao, Y., Ma, D., Yang, Y.-S., Yang, F., Ding, J.-H., Gong, Y., Jiang, L., Ge, L.-P., Wu, S.-Y., Yu, Q., et al. (2022) · Cell Research · doi:10.1038/s41422-022-00614-0 · Cited by 326
Precision Medicine: Disease Subtyping and Tailored Treatment
Wang, R. C., & Wang, Z. (2023) · Cancers · doi:10.3390/cancers15153837 · Cited by 315
bioinformatics tools for mass spectroscopy-based metabolomic data processing and analysis
Sugimoto, M., Kawakami, M., Robert, M., Soga, T., & Tomita, M. (2012) · Current Bioinformatics · doi:10.2174/157489312799304431 · Cited by 307
Dysregulated metabolism contributes to oncogenesis
Hirschey, M. D., DeBerardinis, R. J., Diehl, A. M. E., Drew, J. E., Frezza, C., Green, M. F., Jones, L. W., Ko, Y. H., Le, A., Lea, M. A., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.10.002 · Cited by 305
A distinct glucose metabolism signature of acute myeloid leukemia with prognostic value
Chen, W.-L., Wang, J.-H., Zhao, A.-H., Xu, X., Wang, Y.-H., Chen, T.-L., Li, J.-M., Mi, J.-Q., Zhu, Y.-M., Liu, Y.-F., et al. (2014) · Blood · doi:10.1182/blood-2014-02-554204 · Cited by 302
Self-citationAccurate, Fully-Automated NMR Spectral Profiling for Metabolomics
Ravanbakhsh, S., Liu, P., Bjordahl, T. C., Mandal, R., Grant, J. R., Wilson, M., Eisner, R., Sinelnikov, I., Hu, X., Luchinat, C., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0124219 · Cited by 302
l -2-Hydroxyglutarate: An Epigenetic Modifier and Putative Oncometabolite in Renal Cancer
Shim, E.-H., Livi, C. B., Rakheja, D., Tan, J., Benson, D., Parekh, V., Kho, E.-Y., Ghosh, A. P., Kirkman, R., Velu, S., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0696 · Cited by 280
“Metabolite extraction and Chromatography/Mass Spectrometry of 2-Hydroxyglutarate (2HG) For GC/MS and LC/MS analysis of tissues, human kidney samples including normal and RCC were extracted and prepared for analysis as described in the Supplemental Methods and as previously described(36).”
STATISTICAL METHODS FOR THE ANALYSIS OF HIGH-THROUGHPUT METABOLOMICS DATA
Bartel, J., Krumsiek, J., & Theis, F. J. (2013) · Computational and Structural Biotechnology Journal · doi:10.5936/csbj.201301009 · Cited by 297
Olfactory Detection of Prostate Cancer by Dogs Sniffing Urine: A Step Forward in Early Diagnosis
Cornu, J.-N., Cancel-Tassin, G., Ondet, V., Girardet, C., & Cussenot, O. (2011) · European Urology · doi:10.1016/j.eururo.2010.10.006 · Cited by 295
PSA and beyond: alternative prostate cancer biomarkers
Saini, S. (2016) · Cellular Oncology · doi:10.1007/s13402-016-0268-6 · Cited by 295
Römisch-Margl, W., Prehn, C., Bogumil, R., Röhring, C., Suhre, K., & Adamski, J. (2012) · Metabolomics · doi:10.1007/s11306-011-0293-4 · Cited by 292
Advances in mass spectrometry-based clinical biomarker discovery
Crutchfield, C. A., Thomas, S. N., Sokoll, L. J., & Chan, D. W. (2016) · Clinical Proteomics · doi:10.1186/s12014-015-9102-9 · Cited by 292
Molecular cell biology of androgen receptor signalling
Bennett, N. C., Gardiner, R. A., Hooper, J. D., Johnson, D. W., & Gobe, G. C. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.11.013 · Cited by 292
A Review of Applications of Metabolomics in Cancer
Beger, R. (2013) · Metabolites · doi:10.3390/metabo3030552 · Cited by 288
Wang, X., Sun, H., Zhang, A., Sun, W., Wang, P., & Wang, Z. (2011) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2011.01.042 · Cited by 285
Caveolin-1 and Cancer Metabolism in the Tumor Microenvironment: Markers, Models, and Mechanisms
Sotgia, F., Martinez-Outschoorn, U. E., Howell, A., Pestell, R. G., Pavlides, S., & Lisanti, M. P. (2012) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011811-120856 · Cited by 281
Metabolomics Analysis for Biomarker Discovery: Advances and Challenges
Monteiro, M. S., Carvalho, M., Bastos, M. L., & Guedes de Pinho, P. (2013) · Current Medicinal Chemistry · doi:10.2174/092986713804806621 · Cited by 279
Effects of pre-analytical processes on blood samples used in metabolomics studies
Yin, P., Lehmann, R., & Xu, G. (2015) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-015-8565-x · Cited by 278
Kung, H.-N., Marks, J. R., & Chi, J.-T. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002229 · Cited by 277
“importance in understanding and treating the disease [65,66].”
BackgroundMartinez, V., Mestre, T. C., Rubio, F., Girones-Vilaplana, A., Moreno, D. A., Mittler, R., & Rivero, R. M. (2016) · Frontiers in Plant Science · doi:10.3389/fpls.2016.00838 · Cited by 277
ETS gene fusions in prostate cancer
Clark, J. P., & Cooper, C. S. (2009) · Nature Reviews Urology · doi:10.1038/nrurol.2009.127 · Cited by 276
Recent and potential developments of biofluid analyses in metabolomics
Zhang, A., Sun, H., Wang, P., Han, Y., & Wang, X. (2012) · Journal of Proteomics · doi:10.1016/j.jprot.2011.10.027 · Cited by 276
Early Detection of Recurrent Breast Cancer Using Metabolite Profiling
Asiago, V. M., Alvarado, L. Z., Shanaiah, N., Gowda, G. A. N., Owusu-Sarfo, K., Ballas, R. A., & Raftery, D. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1319 · Cited by 274
Serum metabolomics as a novel diagnostic approach for disease: a systematic review
Zhang, A., Sun, H., & Wang, X. (2012) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-012-6117-1 · Cited by 265
Metabolomics in the study of kidney diseases
Weiss, R. H., & Kim, K. (2012) · Nature Reviews Nephrology · doi:10.1038/nrneph.2011.152 · Cited by 264
A Novel Serum Metabolomics-Based Diagnostic Approach for Colorectal Cancer
Nishiumi, S., Kobayashi, T., Ikeda, A., Yoshie, T., Kibi, M., Izumi, Y., Okuno, T., Hayashi, N., Kawano, S., Takenawa, T., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040459 · Cited by 262
Novel diagnostic biomarkers for prostate cancer
Madu, C. O., & Lu, Y. (2010) · Journal of Cancer · doi:10.7150/jca.1.150 · Cited by 261
Global urinary metabolic profiling procedures using gas chromatography–mass spectrometry
Chan, E. C. Y., Pasikanti, K. K., & Nicholson, J. K. (2011) · Nature Protocols · doi:10.1038/nprot.2011.375 · Cited by 261
Wang, X., Zhang, A., Han, Y., Wang, P., Sun, H., Song, G., Dong, T., Yuan, Y., Yuan, X., Zhang, M., et al. (2012) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m111.016006 · Cited by 258
Single-molecule spectroscopy of amino acids and peptides by recognition tunnelling
Zhao, Y., Ashcroft, B., Zhang, P., Liu, H., Sen, S., Song, W., Im, J., Gyarfas, B., Manna, S., Biswas, S., et al. (2014) · Nature Nanotechnology · doi:10.1038/nnano.2014.54 · Cited by 258
Metabolite extraction from suspension-cultured mammalian cells for global metabolite profiling
Sellick, C. A., Hansen, R., Stephens, G. M., Goodacre, R., & Dickson, A. J. (2011) · Nature Protocols · doi:10.1038/nprot.2011.366 · Cited by 256
Potential metabolite markers of schizophrenia
Yang, J., Chen, T., Sun, L., Zhao, Z., Qi, X., Zhou, K., Cao, Y., Wang, X., Qiu, Y., Su, M., et al. (2013) · Molecular Psychiatry · doi:10.1038/mp.2011.131 · Cited by 253
1H NMR-based Metabolomic Profiling in Mice Infected with Mycobacterium tuberculosis
Shin, J.-H., Yang, J.-Y., Jeon, B.-Y., Yoon, Y. J., Cho, S.-N., Kang, Y.-H., Ryu, D. H., & Hwang, G.-S. (2011) · Journal of Proteome Research · doi:10.1021/pr101054m · Cited by 247
Polysarcosine-containing copolymers: synthesis, characterization, self-assembly, and applications
Birke, A., Ling, J., & Barz, M. (2018) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2018.01.002 · Cited by 229
MyCompoundID: using an evidence-based metabolome library for metabolite identification
Li, L., Li, R., Zhou, J., Zuniga, A., Stanislaus, A. E., Wu, Y., Huan, T., Zheng, J., Shi, Y., Wishart, D. S., et al. (2013) · Analytical Chemistry · doi:10.1021/ac400099b · Cited by 229
Dysregulation of lipids in Alzheimer’s disease and their role as potential biomarkers
Wong, M. W., Braidy, N., Poljak, A., Pickford, R., Thambisetty, M., & Sachdev, P. S. (2017) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2017.01.008 · Cited by 223
“For instance, one mass spectrometry study reported sarcosine as a biomarker for aggressive prostate cancer using prostate biopsy tissue [92].”
Background
Metadata
- Authors
- Sreekumar, A., Poisson, L. M., Rajendiran, T. M., Khan, A. P., Cao, Q., Yu, J., Laxman, B., Mehra, R., Lonigro, R. J., Li, Y., Nyati, M. K., Ahsan, A., Kalyana-Sundaram, S., Han, B., Cao, X., Byun, J., Omenn, G. S., Ghosh, D., Pennathur, S., Alexander, D. C., Berger, A., Shuster, J. R., Wei, J. T., Varambally, S., Beecher, C., & Chinnaiyan, A. M.
- Venue
- Nature
- Published
- 2009-02-01
- Volume
- 457
- Issue
- 7231
- Pages
- 910-914
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2155680682
- Cited by
- 2,234
- References
- 18
- FWCI
- 148.90
- Type
- journal article
- Language
- en
- Update notices
- correction (2013-06-05)
- Open access
- bronze
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.